Posted in | News | Nanoelectronics

Study on Microelectronics Segment of the Compound Semiconductor Industry

The recently published Strategy Analytics GaAs and Compound Semiconductors Service (GaAs) viewpoint, “Compound Semiconductor Industry Review September-November 2010: Microelectronics,” captures significant product, financial, contract and technology announcements for microelectronic companies during the September to November 2010 time-period. Evidenced by continued quarterly revenue growth and numerous product introductions by most companies, Strategy Analytics research shows that the microelectronics segment of the compound semiconductor industry ended 2010 on a strong note and is poised for continued growth in 2011.

“Compound semiconductor device use is driven by the strong consumer electronics market recovery along with continued spending in the aerospace and defense markets,” noted Eric Higham, Director of the Strategy Analytics GaAs and Compound Semiconductor Technologies Service. “GaAs devices remain the most prevalent compound semiconductor option, but several recent product announcements will increase demand for SiGe and GaN devices.”

This viewpoint summarizes financial reports from major GaAs and Silicon suppliers like RFMD, Skyworks Solutions, Hittite, ANADIGICS and NXP. The report lists more than fifty product announcements aimed at a variety of commercial and military end applications, using gallium arsenide (GaAs), gallium nitride (GaN), silicon germanium (SiGe) and complementary metal-oxide-semiconductor (CMOS) technologies. It also captures significant contract, technology and employment developments in the industry.

Source: http://www.strategyanalytics.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.